Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Crit Rev Toxicol. 2020 Jun 29;50(6):463–473. doi: 10.1080/10408444.2020.1773759

Figure 1.

Figure 1.

Structurally diverse ligands that inhibit intestinal colitis/inflammation (Table 1) include 1,4-dihydroxy-2-napthoic acid (DHNA), indole-3-carbinol (I3C), indigo, TCDD, indole-3-aldehyde, ?-naphthoflavone, norisoboldine, 2-(1´-H-indole-3´-carbonyl) thiazole-4-carboxylic acid methyl ester (ITE), and oxazalone.